Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma.
D005755:Gastrins / Q000097:blood* / Q000378:metabolism; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D008297:Male; D008875:Middle Aged; D015282:Octreotide; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D011877:Radionuclide Imaging; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
D005755:Gastrins; D013004:Somatostatin; D015282:Octreotide